Medieage, a Moadata Subsidiary, Selects Hana Securities as Lead Underwriter for IPO

Medieage, a company specializing in digital healthcare data analysis led by CEO Lee Geonwoong, announced on April 22 that it has set a goal to go public next year and has completed the selection and contract signing with Hana Securities as its lead underwriter for the IPO.

As society increasingly values individuals' and families' health and a balanced work-life, the healthcare market has seen the launch of a wide range of health supplements and exercise methods aimed at maintaining and improving personal health. However, unlike the financial sector, where individuals' creditworthiness is defined by credit ratings and used in financial transactions, the healthcare market has lacked an indicator to measure how much an individual's health is improving.

Through over ten years of healthcare data research, Medieage has developed a personal health indicator called "biological age." Just as individuals manage their credit through credit ratings, Medieage is dedicated to helping people manage their health using the "biological age" indicator in an increasingly aging society. The company aims to create a society where everyone can enjoy a healthy and happy life. Currently, hundreds of hospitals, health screening centers, insurance companies, and healthcare platform firms nationwide are utilizing Medieage's diverse health management services.

Founded in 2011 and solely focused on healthcare data research, Medieage achieved management stability after being acquired by Moadata, led by CEO Han Sangjin, in 2023. Medieage is now accelerating the diversification of its services by integrating AI technology through its parent company, Moadata, and launching a variety of digital healthcare services in collaboration with its affiliate bio company, Moa Life Plus. These efforts are expected to drive explosive sales growth this year. In particular, Medieage is recognized for its technological capabilities in healthcare data analysis, including conducting research in partnership with global wearable device companies.

CEO Lee Geonwoong of Medieage stated, "As a company specializing in data analysis in the digital healthcare market, we will focus all our resources on preparing for a KOSDAQ listing, based on sales growth this year and next. Together with Hana Securities, which also served as the underwriter for Moadata's listing, we will once again strive for a successful IPO."